AI-Enabled Optimization of Early-Phase Clinical Trials Faces Architectural Challenges for Real-Time Scaling
2026-06-03
PubComNonGov2026-06-03
Carter Struck
WASHINGTON, June 3 -- Scientix.AI Inc., Austin, Texas, has submitted a public comment letter to the U.S. Food and Drug Administration (FDA) addressing the agency's AI-Enabled Optimization of Early-Pha . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, June 3 -- Scientix.AI Inc., Austin, Texas, has submitted a public comment letter to the U.S. Food and Drug Administration (FDA) addressing the agency's AI-Enabled Optimization of Early-Pha . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026